Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pol J Pathol ; 75(1): 36-39, 2024.
Article in English | MEDLINE | ID: mdl-38741427

ABSTRACT

This research paper evaluates the efficacy of co-testing in precluding cervical cancer, with a particular focus on distinguishable outcomes of the human papillomavirus (HPV) vs. cytology tests. A retrospective review of 5948 patients, who tested positive for high-risk HPV but showed negative cytologic findings, revealed that 15.006% tested positive in subsequent screenings. A comparative analysis of various commercial HPV tests highlighted the precision of mRNA-based HPV testing by Aptima (Hologic) in reducing the likelihood of false-negative cytology. The paper challenges the conviction that a negative cytology alone suffices advocating for a condensed testing interval in instances of positive HPV outcomes, thereby facilitating earlier intervention and optimal preventive care. These findings unveil an exigency for reconsidering preventive strategies based on test outcomes.


Subject(s)
Papillomavirus Infections , Uterine Cervical Neoplasms , Humans , Female , Retrospective Studies , Papillomavirus Infections/virology , Papillomavirus Infections/diagnosis , Papillomavirus Infections/complications , Uterine Cervical Neoplasms/virology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/diagnosis , Adult , Middle Aged , Vaginal Smears , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Aged , Uterine Cervical Dysplasia/virology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/diagnosis , Early Detection of Cancer/methods , Human Papillomavirus Viruses , Cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...